NovoCure Ltd
(MEX:NVCR)
MXN
275.39
0 (0%)
Market Cap: 37.69 Bil
Enterprise Value: 32.64 Bil
PE Ratio: 0
PB Ratio: 5.74
GF Score: 71/100 - Q1 2024 Novocure Ltd Earnings Call TranscriptMay 02, 2024MXN275.39Earnings
- Q4 2023 Novocure Ltd Earnings Call TranscriptFeb 22, 2024MXN275.39Earnings
- Novocure Ltd at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Novocure Ltd at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Q3 2023 Novocure Ltd Earnings Call TranscriptOct 26, 2023MXN275.39Earnings
- Novocure Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Novocure Ltd at Wells Fargo Healthcare Conference TranscriptSep 07, 2023
- Q2 2023 Novocure Ltd Earnings Call TranscriptJul 27, 2023MXN694.37Earnings
- Novocure Ltd LUNAR Phase 3 Clinical Trial Presentation TranscriptJun 06, 2023
- Q1 2023 Novocure Ltd Earnings Call TranscriptMay 04, 2023MXN1080.24Earnings
- Q4 2022 Novocure Ltd Earnings Call TranscriptFeb 23, 2023MXN1555Earnings
- Novocure Ltd at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Novocure Ltd at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Q3 2022 Novocure Ltd Earnings Call TranscriptOct 27, 2022MXN1307.95Earnings
- Novocure Ltd at Wells Fargo Healthcare Conference TranscriptSep 07, 2022
- Q2 2022 Novocure Ltd Earnings Call TranscriptJul 28, 2022MXN1454.46Earnings
- Q1 2022 Novocure Ltd Earnings Call TranscriptApr 28, 2022MXN1614Earnings
- Q4 2021 Novocure Ltd Earnings Call TranscriptFeb 24, 2022MXN1521.03Earnings
- Novocure Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Novocure Ltd at Piper Sandler Healthcare Conference (Virtual) TranscriptNov 30, 2021
- Q3 2021 Novocure Ltd Earnings Call TranscriptOct 28, 2021Earnings
- Novocure Ltd at Wells Fargo Virtual Healthcare Conference TranscriptSep 10, 2021
- Q2 2021 Novocure Ltd Earnings Call TranscriptJul 29, 2021Earnings
- Q1 2021 Novocure Ltd Earnings Call TranscriptApr 29, 2021Earnings
- Q4 2020 Novocure Ltd Earnings Call TranscriptFeb 25, 2021Earnings
- Novocure Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Novocure Ltd at Evercore ISI HealthCONx Conference (Virtual) - Fireside Chat TranscriptDec 02, 2020
- Novocure Ltd Virtual Research & Development Day TranscriptNov 12, 2020
- Q3 2020 Novocure Ltd Earnings Call TranscriptOct 29, 2020Earnings
- Novocure Ltd at Wells Fargo Virtual Healthcare Conference TranscriptSep 09, 2020
- Q2 2020 Novocure Ltd Earnings Call TranscriptJul 30, 2020Earnings
- Q1 2020 Novocure Ltd Earnings Call TranscriptApr 30, 2020Earnings
- Q4 2019 Novocure Ltd Earnings Call TranscriptFeb 27, 2020Earnings
- Novocure Ltd at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Novocure Ltd Earnings Call TranscriptOct 31, 2019Earnings
- Q2 2019 Novocure Ltd Earnings Call TranscriptJul 25, 2019Earnings
- Q1 2019 Novocure Ltd Earnings Call TranscriptMay 02, 2019Earnings
- Q4 2018 Novocure Ltd Earnings Call TranscriptFeb 28, 2019Earnings
Novocure Ltd at Wells Fargo Virtual Healthcare Conference Transcript
Sep 09, 2020 / 12:40PM GMT
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
I'm Larry Biegelsen, the medical device analyst at Wells Fargo. I'm pleased to introduce the next company in our morning session on day 1 of our 2020 Virtual Health Care Conference, NovoCure. Joining us from the company are the Executive Chairman, Bill Doyle; and Chief Scientific Officer, Dr. Uri Weinberg. In terms of format, it will be a 30-minute fireside chat. So Bill and Uri, welcome, and thank you for joining us.
Uri Weinberg
NovoCure Limited - Chief Science Officer
Thanks for having us, Larry. It's our pleasure to be here.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Good. So we're going to try something a little different. We're going to try to do 1 audience polling question this morning. And we'll prompt the audience at the appropriate time. But Bill, let's quickly touch upon COVID before
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)